Selenate specifically sensitizes drug-resistant cancer cells by increasing apoptosis via G2 phase cell cycle arrest without P-GP inhibition. - Choi, Ae-Ran; Jee Jo, Min; Jung, Myung-Ji; Sik Kim, Hyung; Yoon, Sungpil (European Journal of Pharmacology, 2015)